New Report: Society Pass (SOPA), Our #1 Internet Company Trading Under $5.00.

Our #1 Internet Company Trading Under $5.00, Society Pass Holds Appeal for Both Traders and Long-Term Investors.

Initiating Coverage on Society Pass (SOPA).

Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley

Society Pass (SOPA) Research Reports

RESEARCH REPORT ARCHIVE December 27th, 2023. Litchfield Hills Research - $4.00 Price Target.

Smart For Life (SMFL) $0.37 Announces Initiation of Equity Analyst Coverage by Dawson James...

Initiates with “Buy” recommendation and $8 price target. MIAMI, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Smart for Life,...

Report: Kerrisdale Capital on Up Fintech Holding (TIGR).

The Robinhood of China? If They Liked it at $18, They've got to Love it at $4.00!
Mitesco

Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165% Potential Gain.

LIVE QUOTE Original Report: Initiating Coverage...

Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next Success Story in...

New Report on Revive Therapeutics (RVVTF, RVV). Ushering in Advances in Anti-Inflammatory and Antioxidant Drugs, as a Tool Against Covid.
Revive Therapeutics

Revive Therapeutics (RVVTF, RVV): Updates and News Archive.

Recent Headlines (See FDA Filing Submission at Bottom) LIVE QUOTE

Track Record

Click to open 21 clients up over $100 million, 13 clients up over ten-fold in value. Over $30 billion...
CPRE Networks

Adding VYRE Network (CAPV) to the Watch List.

Look What We Found. Our First Internet Play in Ages, And It's a Doozy. We would categorize this...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...